Sterile Value Stream Director: Lead Transformation

GlaxoSmithKline; Barnard Castle; On-site; GBP 80,000 - 100,000; Full time

Job summary

A leading biopharmaceutical company located in Barnard Castle is seeking a Sterile Value Stream Director to lead the strategic transformation of sterile operations. This high-impact leadership role demands extensive experience in sterile manufacturing, strategic thinking, and the ability to foster high-performing teams. The successful candidate will be accountable for ensuring compliance and quality while driving efficiency and continuous improvement across diverse product modalities, including monoclonal antibodies and oligonucleotides.

Benefits

Competitive salary

Leadership development programs

Global collaboration opportunities

Qualifications

• Extensive experience in sterile pharmaceutical manufacturing, including aseptic processing.
• Proven capability to lead large-scale change across operations.
• Strong understanding of compliance and regulatory requirements.

Responsibilities

• Define and execute the sterile value stream strategy for transformation.
• Lead change management programs and sustain operational excellence.
• Build high-performing leadership teams and develop succession plans.

Skills

Strategic Leadership

Lean Six Sigma

Coaching and mentoring

Change management

Stakeholder management

Education

Bachelor’s degree in Business, Engineering, Operations, Supply Chain, or Quality Management

Tools

Aseptic Filling Technologies

eBatch Records (eBRS)

Job description

A leading biopharmaceutical company located in Barnard Castle is seeking a Sterile Value Stream Director to lead the strategic transformation of sterile operations. This high-impact leadership role demands extensive experience in sterile manufacturing, strategic thinking, and the ability to foster high-performing teams. The successful candidate will be accountable for ensuring compliance and quality while driving efficiency and continuous improvement across diverse product modalities, including monoclonal antibodies and oligonucleotides.